Testing the Effect of Whole-wheat Sourdough Bread Compared to White Bread on Healthy Individuals

October 14, 2016 updated by: Tel-Aviv Sourasky Medical Center

Testing the Effect of Whole-wheat Sourdough Bread Compared to White Bread on Healthy Individuals: Randomized Trial

Bread is the most common grain product in the world, with consumption surpassing 3 billion individuals per year. Sourdough whole-grain bread is considered a healthy alternative to white, refined-wheat bread.

This cross-over study will test the effect of consumption of sourdough bread compared to white bread following a short dietary intervention period (one week) on multiple clinical parameters and gut microbiota.

Study Overview

Study Type

Interventional

Enrollment (Actual)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Rehovot, Israel
        • Weizmann Institute of Science
      • Tel Aviv, Israel, 64239
        • Department of Gastroentherology

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 70 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Able to provide and signed informed consent form
  • Over 18 years
  • Not in active military service
  • Ability to technically operate a glucometer

Exclusion Criteria:

  • Prediagnosed type I / type II diabetes mellitus
  • Pregnancy
  • Usage of antibiotics within three months prior to participation
  • Chronically active inflammatory or neoplastic disease in the three years prior to enrollment
  • Skin disease, including contact dermatitis, precluding proper attachment of the continuous glucose monitor

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: BASIC_SCIENCE
  • Allocation: RANDOMIZED
  • Interventional Model: CROSSOVER
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Sourdough bread, white bread
Consumption of sourdough bread for one week, 2 week washout, consumption of white bread for one week
Participants will be given sourdough bread to consume instead of other wheat products. 145g will be consumed every morning in addition to ad libitum consumption throughout the day (matched between first and second intervention periods)
Participants will be given white bread to consume instead of other wheat products. 110g will be consumed every morning in addition to ad libitum consumption throughout the day (matched between first and second intervention periods)
Other: White bread, sourdough bread
Consumption of white bread for one week, 2 week washout, consumption of sourdough bread for one week
Participants will be given sourdough bread to consume instead of other wheat products. 145g will be consumed every morning in addition to ad libitum consumption throughout the day (matched between first and second intervention periods)
Participants will be given white bread to consume instead of other wheat products. 110g will be consumed every morning in addition to ad libitum consumption throughout the day (matched between first and second intervention periods)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes to glycemic control
Time Frame: One week
Measured as response to an Oral Glucose Tolerance Test (OGTT; mg/dl*h).
One week
Changes to glycemic control
Time Frame: One week
Measured as blood glucose levels at wake-up (mg/dl).
One week

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes to total cholesterol levels (mg/dl)
Time Frame: One week
Measured by a blood test.
One week
Changes to HDL cholesterol levels (mg/dl)
Time Frame: One week
Measured by a blood test.
One week
Changes to LDL cholesterol levels (mg/dl)
Time Frame: One week
Measured by a blood test.
One week
Changes to triglycerides levels (mg/dl)
Time Frame: One week
Measured by a blood test.
One week
Changes to C-Reactive Protein (CRP) levels (mg/l)
Time Frame: One week
Measured by a blood test.
One week
Changes to weight (Kg.)
Time Frame: One week
One week
Changes to Basal Metabolic Rate (BMR; J)
Time Frame: One week
One week
Changes to blood pressure (mmHg)
Time Frame: One week
One week
Changes to Alanine Transaminase (ALT) levels (IU/l)
Time Frame: One week
Measured by a blood test.
One week
Changes to Aspartate Transaminase (AST) levels (IU/I)
Time Frame: One week
Measured by a blood test.
One week
Changes to Gamma-Glutamyl Transpeptidase (GGT) levels (IU/l)
Time Frame: One week
Measured by a blood test.
One week
Changes to Creatinine levels (mg/dl)
Time Frame: One week
Measured by a blood test.
One week
Changes to Magnesium levels (mg/dl)
Time Frame: One week
Measured by a blood test.
One week
Changes to Calcium levels (mg/dl)
Time Frame: One week
Measured by a blood test.
One week
Changes to Iron levels (mg/dl)
Time Frame: One week
Measured by a blood test.
One week
Changes to Urea levels (mg/dl)
Time Frame: One week
Measured by a blood test.
One week
Changes to Lactate Dehydrogenase (LDH) levels
Time Frame: One week
Measured by a blood test (IU/l)
One week
Changes to Thyroid Stimulating Hormone (TSH)
Time Frame: One week D
Measured by a blood test (mIU/ml)
One week D

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes to gut microbiome composition and function
Time Frame: One week
Measured by metagenomic sequencing
One week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

February 1, 2016

Primary Completion (Actual)

May 1, 2016

Study Completion (Actual)

September 1, 2016

Study Registration Dates

First Submitted

October 13, 2016

First Submitted That Met QC Criteria

October 14, 2016

First Posted (Estimate)

October 18, 2016

Study Record Updates

Last Update Posted (Estimate)

October 18, 2016

Last Update Submitted That Met QC Criteria

October 14, 2016

Last Verified

October 1, 2016

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • TASMC-12-ZH-658A

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Body Weight Changes

Clinical Trials on Consumption of sourdough bread

Subscribe